PHARMACEUTICAL DOSAGE FORMS COMPRISING POLY(EPSILON-CAPROLACTONE) AND POLYETHYLENE OXIDE

摘要

The present invention relates to a solid extended release pharmaceutical dosage form, comprising a mixture in the form of an extended release matrix formulation, the mixture comprising at least: (1) at least one poly(ε-caprolactone), and (2) at least one polyethylene oxide, and (3) at least one active agent.

主权项

1. A solid extended release pharmaceutical dosage form, comprising a mixture in the form of an extended release matrix formulation, the mixture comprising at least:
(1) at least one poly(ε-caprolactone) having an approximate number average molecular weight of from about 10,000 to about 200,000, and (2) at least one polyethylene oxide having an approximate weight average molecular weight of from about 10,000 to less than 1,000,000, and (3) at least one active agent.